Stay updated on CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial
Sign up to get notified when there's something new on the CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial page.

Latest updates to the CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe record displays details of the completed Phase 3 rheumatoid arthritis trial, including its interventions, eligibility criteria, primary outcome, location, and study dates.SummaryDifference37%

- Check15 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the study record remains inaccessible with a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record content, indicating an access issue while the site chrome remains visible.SummaryDifference16%

Stay in the know with updates to CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial page.